List of works - Joerg Schuettrumpf

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway

scientific article

Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A

scientific article

Clinical assessment of efficacy and safety of DDAVP

scientific article published on November 1, 2010

Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice ⬇️

scientific article published on October 26, 2011

Factor IX variants improve gene therapy efficacy for hemophilia B.

scientific article

Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIII.

scientific article published in November 2009

Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations

scientific article

Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector

scientific article

Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease

scientific article published on 01 September 1997

Next generation FIX muteins with FVIII-independent activity for alternative treatment of hemophilia A.

scientific article

No detection of the retrovirus xenotropic murine leukemia virus-related virus in individuals with hemophilia.

scientific article

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene.

scientific article published on 24 June 2004

Oral gene therapy for hemophilia B using chitosan-formulated FIX mutants

scientific article published on June 2014

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.

scientific article

Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX

scientific article published on 06 December 2010

[Non-viral gene transfer results in therapeutic factor IX levels in haemophilia B mice]

scientific article published on 01 October 2008

[Potential of hematopoietic stem cells as the basis for generation of advanced therapy medicinal products]

scientific article published on 01 July 2011

List of works by Joerg Schuettrumpf

A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway

Chemical chaperones improve protein secretion and rescue mutant factor VIII in mice with hemophilia A

Clinical assessment of efficacy and safety of DDAVP

Engineered factor IX variants bypass FVIII and correct hemophilia A phenotype in mice ⬇️

Factor IX variants improve gene therapy efficacy for hemophilia B.

Factor VIII-eGFP fusion proteins with preserved functional activity for the analysis of the early secretory pathway of factor VIII.

Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations

Improved hepatic gene transfer by using an adeno-associated virus serotype 5 vector

Increased prevalence of a polymorphism in the gene coding for human prothrombin in patients with coronary heart disease

Next generation FIX muteins with FVIII-independent activity for alternative treatment of hemophilia A.

No detection of the retrovirus xenotropic murine leukemia virus-related virus in individuals with hemophilia.

Novel hemophilia B mouse models exhibiting a range of mutations in the Factor IX gene.

Oral gene therapy for hemophilia B using chitosan-formulated FIX mutants

Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1.

Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX

[Non-viral gene transfer results in therapeutic factor IX levels in haemophilia B mice]

[Potential of hematopoietic stem cells as the basis for generation of advanced therapy medicinal products]